https://www.pharmavoice.com/news/sarepta-elevidys-patient-death-gene-therapy-risk/743051/
Teen’s death following Sarepta DMD gene therapy underscores a risk seen for decades | PharmaVoice
The death of a 16-year-old boy evokes a lengthy battle to realize the benefit of cutting-edge gene therapy while also enduring tragic risk.
gene therapydeathfollowingsareptadmd
https://www.pharmavoice.com/
Pharma Industry News | PharmaVoice
PharmaVoice provides a forum for industry leaders to hear the most important voices and ideas in the industry. PharmaVoice is a leading industry publication...
pharma industrynewspharmavoice
https://www.pharmavoice.com/news/doctor-dealmaker-reveals-ma-playbook-nuvation/824155/
Doctor-turned-dealmaker reveals his M&A playbook | PharmaVoice
Dr. David Hung is pulling multiple financial levers to put Nuvation Bio on strong footing as it advances its oncology drugs.
m adoctorturneddealmakerreveals
https://www.pharmavoice.com/news/biogen-reata-acquisition-MA-biopharma/690460/
Biogen’s Reata acquisition reflects biopharma’s inevitable M&A, IPO return to growth | PharmaVoice
m areataacquisitionreflectsinevitable
https://www.1888pressrelease.com/pharmavoice-names-two-publicis-touchpoint-solutions-executiv-pr-538630.html
Pharmavoice Names Two Publicis Touchpoint Solutions Executives Among 100 Influential Healt by...
Pharmavoice Names Two Publicis Touchpoint Solutions Executives Among 100 Influential Healthcare Leaders, Rick Keefer receives inaugural Red Jacket Award;...
pharmavoicenamestwopublicistouchpoint
https://www.pharmavoice.com/news/new-capsida-biotherapeutics-ceo-peter/618168/
New Capsida Biotherapeutics CEO Peter Anastasiou aims to bring AAV therapy to reality | PharmaVoice
Read what Capsida CEO Peter Anastasiou has planned for his new role.
newbiotherapeuticsceopeteranastasiou